Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.82 USD | +0.31% | -0.99% | +22.01% |
May. 16 | Argus Downgrades Catalent to Sell From Buy | MT |
May. 14 | Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal | MT |
Financials (USD)
Sales 2024 * | 4.34B | Sales 2025 * | 4.6B | Capitalization | 9.92B |
---|---|---|---|---|---|
Net income 2024 * | -896M | Net income 2025 * | 12M | EV / Sales 2024 * | 3.42 x |
Net Debt 2024 * | 4.95B | Net Debt 2025 * | 4.48B | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
-11.1
x | P/E ratio 2025 * |
791
x | Employees | 17,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.83% |
Latest transcript on Catalent, Inc.
1 day | +0.31% | ||
1 week | -0.99% | ||
Current month | -1.84% | ||
1 month | -1.76% | ||
3 months | -6.72% | ||
6 months | +37.08% | ||
Current year | +22.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 10-09-30 | |
Matti Masanovich
DFI | Director of Finance/CFO | 52 | 23-07-04 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | 14-07-31 |
John Greisch
CHM | Chairman | 68 | 18-02-15 |
J. Carroll
BRD | Director/Board Member | 74 | 15-07-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 2 M€ | -.--% | ||
1.21% | 8 M€ | +4.90% | ||
0.83% | 2 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 54.82 | +0.31% | 1,755,897 |
24-05-23 | 54.65 | -0.58% | 1,342,524 |
24-05-22 | 54.97 | +0.02% | 1,440,654 |
24-05-21 | 54.96 | -0.07% | 1,332,970 |
24-05-20 | 55 | -0.67% | 921,831 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.01% | 9.92B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- CTLT Stock